Fundraising Fox

Kris Elverum

Executive at ロゴマーク：AIRNA

Cambridge, Massachusetts, United States

Find your path to Kris

920 people in our graph share verified history with Kris — schools, employers, funds. One of them is your warm intro.

Laura BuhlerunlockedKris: together at McKinsey & Company (2009–2010)
×9Kris: together at McKinsey & Company
Kris: together at Rubius Therapeutics
Kris: together at UMN Carlson School of Management

About

Kris Elverum is an advisor at AIRNA, where he previously served as President and CEO. During his tenure, AIRNA, an RNA editing therapeutics company, raised $215 million in capital, expanded to a team of more than 70 people, and advanced its work from academic research to clinical stages. Earlier in his career he was President and CEO of Diagon Therapeutics, led business and corporate development at Rubius Therapeutics, Turnstone Biologics, and SQZ Biotechnologies, and held roles at Novartis and McKinsey & Co.; he holds an MBA and BS from the University of Minnesota's Carlson School of Management.

Executive at ロゴマーク：AIRNA

Intro paths

→

In turn, Kris can intro founders to ロゴマーク：AIRNA's investors below.

ロゴマーク：AIRNA's investors · 9

+ND CapitalWoodside · $540K – $5.4M checks · since 2021ARCH Venture PartnersChicago · $50K – $250M checks · since 2021Fast Track InitiativeTokyo · $1.2M – $184M checks · since 2021ForbionNaarden · since 2021Nextech InvestZurich · $648K – $3.2M checks · since 2021Novalis LifeSciencesPortsmouth · since 2021Ono Venture Investment, Inc.South San Francisco · since 2021Pathway BioventuresChicago · since 2021VenrockPalo Alto · $500K – $10M checks · since 2021

Co-founders at ロゴマーク：AIRNA

TSThorsten Stafforst
Thorsten StafforstChairman of the Board of Directors

Experience

  1. AIRNAAdvisorcurrent2026 — presentCambridge, MA
  2. AIRNAPresident and Chief Executive Officer2023 — 2026Cambridge, MA
  3. Navega TherapeuticsMember of the Board of Advisorscurrent2022 — presentSan Diego Metropolitan Area
  4. Self employedConsultant and Advisor2022 — 2023Boston, Massachusetts, United States
  5. 4:59 NewCo, a 5AM Ventures CompanyPresident and Chief Executive Officer2021 — 2022Cambridge, MA
  6. Rubius TherapeuticsSVP of Business Development and Strategy2019 — 2021Greater Boston Area
  7. Turnstone BiologicsSVP of Corporate Development2017 — 2019Greater New York City Area
  8. SQZ BiotechChief Business Officer2016Greater Boston Area
  9. NovartisCell and Gene Therapies, US CAR T cell Marketing2014 — 2016East Hanover, New Jersey
  10. NovartisGilenya Account Manager2013 — 2014East Hanover, New Jersey, USA
  11. NovartisSandoz Global Head of Strategy and Market Intelligence; Sandoz Executive Committee Member2011 — 2013Munich Area, Germany
  12. NovartisSandoz Assistant to CEO2010 — 2011Munich Area, Germany
  13. McKinsey & CompanyEngagement Manager2009 — 2010San Francisco Bay Area
  14. Self employedWriter2008 — 2009
  15. McKinsey & CompanyEngagement Manager2006 — 2008San Francisco Bay Area
  16. McKinsey & CompanyAssociate2003 — 2005Washington D.C. Metro Area
  17. Merrill LynchFinancial Advisor1998 — 2001

Skills & more

Sales OperationsStrategy35Business Development22Business Strategy15Mergers & Acquisitions9Business Planning5Pricing3Strategic Planning3Leadership3Management1Pharmaceutical Industry3Competitor Intelligence1
+12 moreEmotional IntelligenceInterpersonal SkillMarket IntelligenceProduct DevelopmentSalesSegmentationMergersOncologyBiotechnologyProduct LaunchManaged CarePharmaceutical Sales

From Kris's professional profile.

Frequently asked questions

Who is Kris Elverum?
Kris Elverum is an advisor at AIRNA, where he previously served as President and CEO. During his tenure, AIRNA, an RNA editing therapeutics company, raised $215 million in capital, expanded to a team of more than 70 people, and advanced its work from academic research to clinical stages. Earlier in his career he was President and CEO of Diagon Therapeutics, led business and corporate development at Rubius Therapeutics, Turnstone Biologics, and SQZ Biotechnologies, and held roles at Novartis and McKinsey & Co.; he holds an MBA and BS from the University of Minnesota's Carlson School of Management.
Where did Kris Elverum go to school?
Kris Elverum studied at UMN Carlson School of Management (M.B.A); UMN Carlson School of Management (B.S in Business; Minor in Chemistry).

Same school

Also attended UMN Carlson School of Management137

Todd ChaffeeInvestor at IVP (Institutional Venture Partners)Troy ArnoldPartner, Echo Health Advisors at Echo Health VenturesEliseInvestor at Mairs & Power VCAndrew HeimGeneral Partner at Arthur VenturesNing LiVenture Partner at Foothill VenturesFelix ZhangVenture Partner at Artesian

+ 131 more

Shared employers

Also worked at Navega Therapeutics1

Fernando AlemanExecutive Officer, Director at Navega Therapeutics

Also worked at Turnstone Biologics6

Kenneth GriséPrincipal at Sixty Degree CapitalMaura CampbellBoard Director at FACIT (Fight Against Cancer Innovation Trust)Patrick McCallExecutive Officer at In8BioWendy WorcesterExecutive Officer, Director at Anyone HomeJane HendersonExecutive Officer at Adagio TherapeuticsWilliam WaddillExecutive Officer at Calithera Biosciences

Also worked at SQZ Biotech9

Ellie McGuireManaging Partner at Polaris PartnersTravis FlemingAnalyst at 5AM VenturesJonathan BehrPartner at SV Health InvestorsOliver Rosen, M.D.Executive Officer at Deciphera PharmaceuticalsBruce BeutelExecutive Officer at Dewpoint TherapeuticsArmon ShareiExecutive Officer, Director at Portal Biotechnologies

+ 3 more

Also worked at Novartis330

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 324 more